Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03260712
Title Pembrolizumab in Biliary Tract Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors European Organisation for Research and Treatment of Cancer - EORTC
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR | ESP | DEU

Facility Status City State Zip Country Details
Universitaetsklinikum Leipzig UCCL-Krebszentrum Leipzig 04103 Germany Details
Universitaetsmedizin der Johannes Gutenberg Universitaet Mainz-University Medical Center Mainz 55131 Germany Details
Vall d'Hebron Institut Oncologia Barcelona Spain Details
Hospital Universitario 12 De Octubre Madrid Spain Details
University College London Hospitals NHS Foundation Trust - University College Hospital London NW1 2PG United Kingdom Details
The Christie NHS Foundation Trust Manchester M20 4BX United Kingdom Details
Nottingham University Hospitals NHS Trust - City Hospital Nottingham NG5 1PB United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field